SHIRE Hellas S.A.



Managing Director:
Dr Christos Dakas

Number of Employees (31/12/2010):

Turnover (drugs) or medical devices (31/12/2010):
4.500.000 €

Our purpose, mission and strategy:

As one of the world’s leading specialty biopharmaceutical companies, Shire has emerged as a company fully focused on a single purpose: to enable people with life-altering conditions to lead better lives.

Through our Shire Human Genetic Therapies (HGT) business, we pursue opportunities on behalf of patients and families facing such rare diseases as Fabry disease, Hunter syndrome, Gaucher disease, hereditary angioedema, and metachromatic leukodystrophy—patients whose very lives often hinge on the discovery and delivery of extraordinary medicines.

Through our Specialty Pharma business, meanwhile, we develop and distribute an innovative portfolio of treatments for patients with ADHD, ulcerative colitis, and end-stage renal disease. Our commitment throughout is on symptomatic diseases, treated by specialist physicians. We take the risks we need to take so that we might change lives for the discernible better.

At Shire we are perpetually planning for the future. We’re asking ourselves what more we can do to make this world a healthier place and in doing so, we’re mindful of our overall cultural ethos; to be as brave as the people we help.


The National Organization for Rare Diseases (NORD) honors Shire with the 2010 Partners in Progress Corporate Award in recognition of the accelerated development of VPRIV (velaglucerase alfa for injection), a new treatment for Gaucher patients, providing this therapy to patients through early access programs ahead of commercial approval – May 2010

Shire’s Corporate Communications team receives top honors in the annual PR Week Awards, which are among the most prestigious honors in the communications industry and presented by PR Week magazine in the US – March 2010
Shire is named as one of the most admired companies in the health sector by UK publication Management Today magazine – December 2009
Shire CEO Angus Russell is named one of the 100 Most Inspiring People in the Life Sciences Industry by PharmaVoice magazine – July 2009

38, Vasileos Konstantinou Avenue, P.C.11635, Athens

+30 210 7245670

+30 210 7243357


[email protected]